Buscar
-
Tetrahydrobiopterin modulates the behavioral neuroinflammatory response to an LPS challenge in mice
(Brain, Behavior, and Immunity. vol. 105, pp. 139-148, 2022-10)Article de revue -
Cytokine-induced depression: current status and novel targets for depression therapy.
(CNS and Neurological Disorders. Drug Targets. vol. 13, n° 6, pp. 1066-74, 2014-01-01)Article de revue -
The neuroimmune basis of fatigue.
(Trends in Neurosciences. vol. 37, n° 1, pp. 39-46, 2014-01-01)Article de revue -
Chronic low-grade inflammation in metabolic disorders: relevance for behavioral symptoms.
(Neuroimmunomodulation. vol. 21, n° 2-3, pp. 95-101, 2014-01-01)Article de revue -
Serotonin and interleukin-6: the role of genetic polymorphisms in IFN-induced neuropsychiatric symptoms.
(Psychoneuroendocrinology. vol. 38, n° 9, pp. 1803-13, 2013-09-01)Article de revue -
A response to the commentary "Indolamine 2,3-dioxygenase regulation and neuropsychiatric symptoms" by Loftis, J.M. on "Serotonin and interleukin-6: the role of genetic polymorphisms in IFN-induced neuropsychiatric symptoms" by Udina, M., Moreno-España, J., Navinés, R., Gimenez, D., Langohr, K., Gratacòs, M., Capuron, L., de la Torre, R., Solà, R., Martin-Santos, R. http:\\dx.doi.org/10.1016/j.psyneuen.2013.03.007.
(Psychoneuroendocrinology. vol. 38, n° 9, pp. 1830-1, 2013-09-01)Article de revue -
Fatigue symptoms relate to systemic inflammation in patients with type 2 diabetes.
(Brain, Behavior, and Immunity. vol. 26, n° 8, pp. 1211-9, 2012-11-01)Article de revue